# Defining Remission With Etanercept in AS in Real Life Clinical Practice

> **NCT02202850** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 84 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** etanercept
- **DRUG:** etanercept

## Key facts

- **NCT ID:** NCT02202850
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-12
- **Primary completion:** 2017-04-26
- **Final completion:** 2017-04-26
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2018-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02202850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02202850, "Defining Remission With Etanercept in AS in Real Life Clinical Practice". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02202850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*